A New Horizon in Nephrology: Finerenone Shows Promise for Non-Diabetic Chronic Kidney Disease
Comments Off on A New Horizon in Nephrology: Finerenone Shows Promise for Non-Diabetic Chronic Kidney Disease
July 18, 2026
In a landmark development for nephrology, a major international clinical trial has revealed that the drug finerenone can significantly slow the progression of chronic kidney disease (CKD) in patients who do not suffer from diabetes. This breakthrough,…
